Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (181-190 of 8,369) with videos related to

Pageof 837
Sort By:
Drugs|February 12, 2022
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence"Mario Gennaro Mazza, Benedetta Vai, Livia De Picker, et al.
Drugs|October 7, 2021
Pharmacological Management of Acute Endodontic PainAsma A Khan, Anibal Diogenes
Drugs|February 23, 2022
Olverembatinib: First ApprovalSohita Dhillon
Drugs|March 1, 1986
Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?H O Klein, E Kaplinsky
Drugs|April 13, 2022
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain AmyloidosisHannah A Blair
Drugs|January 29, 2022
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future DirectionsIslam Y Elgendy, Lina Ya'Qoub, Kuan-Han Chen, et al.
Drugs|September 23, 2021
Anifrolumab: First ApprovalEmma D Deeks
Drugs|July 13, 2022
Tirzepatide: First ApprovalYahiya Y Syed
Drugs|April 27, 2022
Faricimab: First ApprovalMatt Shirley
Drugs|April 27, 2022
Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy IndividualsFabrizio Schifano, Valeria Catalani, Safia Sharif, et al.
Pageof 837

Showing results (181-190 of 8,369) with videos related to

Sort By:
Pageof 837
Drugs|February 12, 2022
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence"Mario Gennaro Mazza, Benedetta Vai, Livia De Picker, et al.
Drugs|October 7, 2021
Pharmacological Management of Acute Endodontic PainAsma A Khan, Anibal Diogenes
Drugs|February 23, 2022
Olverembatinib: First ApprovalSohita Dhillon
Drugs|March 1, 1986
Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?H O Klein, E Kaplinsky
Drugs|April 13, 2022
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain AmyloidosisHannah A Blair
Drugs|January 29, 2022
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future DirectionsIslam Y Elgendy, Lina Ya'Qoub, Kuan-Han Chen, et al.
Drugs|September 23, 2021
Anifrolumab: First ApprovalEmma D Deeks
Drugs|July 13, 2022
Tirzepatide: First ApprovalYahiya Y Syed
Drugs|April 27, 2022
Faricimab: First ApprovalMatt Shirley
Drugs|April 27, 2022
Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy IndividualsFabrizio Schifano, Valeria Catalani, Safia Sharif, et al.
Pageof 837